Page last updated: 2024-11-01

nicardipine and Asphyxia Neonatorum

nicardipine has been researched along with Asphyxia Neonatorum in 1 studies

Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.

Asphyxia Neonatorum: Respiratory failure in the newborn. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levene, MI1
Gibson, NA1
Fenton, AC1
Papathoma, E1
Barnett, D1

Other Studies

1 other study available for nicardipine and Asphyxia Neonatorum

ArticleYear
The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants.
    Developmental medicine and child neurology, 1990, Volume: 32, Issue:7

    Topics: Asphyxia Neonatorum; Blood Pressure; Brain Damage, Chronic; Cerebral Cortex; Cerebrovascular Circula

1990